Home/Filings/4/0001209191-17-066819
4//SEC Filing

Powala Christopher 4

Accession 0001209191-17-066819

CIK 0001557746other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:57 PM ET

Size

15.7 KB

Accession

0001209191-17-066819

Insider Transaction Report

Form 4
Period: 2017-12-15
Powala Christopher
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-12-15+1,300132,865 total
  • Tax Payment

    Common Stock

    2017-12-18$24.12/sh494$11,915133,601 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-12-181,6253,250 total
    Common Stock (1,625 underlying)
  • Exercise/Conversion

    Common Stock

    2017-12-18+1,625134,095 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-12-151,3009,100 total
    Common Stock (1,300 underlying)
  • Tax Payment

    Common Stock

    2017-12-15$24.23/sh395$9,571132,470 total
Holdings
  • Common Stock

    (indirect: By Trust)
    130,434
Footnotes (5)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
  • [F3]These shares are held by the Christopher V. Powala Aclaris Irrevocable Trust, for which Mr. Powala serves as trustee.
  • [F4]On December 15, 2016, the reporting person was granted 10,400 restricted stock units, with 50% of the shares underlying the restricted stock units vesting in four equal annual installments beginning on December 15, 2017 and the other 50% of the shares underlying these restricted stock units vesting upon the achievement of a specified commercial milestone, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
  • [F5]On December 18, 2015, the reporting person was granted 6,500 restricted stock units, vesting in four equal annual installments beginning on December 18, 2016, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.

Issuer

Aclaris Therapeutics, Inc.

CIK 0001557746

Entity typeother

Related Parties

1
  • filerCIK 0001654301

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:57 PM ET
Size
15.7 KB